This $1.24 million award will be split among MCB Professor Jennifer Doudna, and her collaborator, Emmanuelle Charpentier of the Max Planck Institute of Infection Biology in Germany and Umeå University in Sweden, as well as Feng Zhang of MIT. They were awarded “for the development of CRISPR/Cas9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment.”
Photo credit: Keegan Houser.